SOBR Safe, Inc. (NASDAQ:SOBR – Get Free Report) was the target of a significant decline in short interest during the month of December. As of December 15th, there was short interest totaling 1,905 shares, a decline of 31.7% from the November 30th total of 2,790 shares. Approximately 0.1% of the company’s stock are short sold. Based on an average daily trading volume, of 100,033 shares, the short-interest ratio is presently 0.0 days. Based on an average daily trading volume, of 100,033 shares, the short-interest ratio is presently 0.0 days. Approximately 0.1% of the company’s stock are short sold.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of SOBR Safe in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.
Check Out Our Latest Analysis on SOBR Safe
Institutional Trading of SOBR Safe
SOBR Safe Trading Down 7.8%
NASDAQ SOBR traded down $0.19 during trading hours on Tuesday, reaching $2.20. The company’s stock had a trading volume of 991,888 shares, compared to its average volume of 921,059. The stock has a market cap of $3.34 million, a PE ratio of -0.02 and a beta of 0.66. The business has a 50-day simple moving average of $2.24 and a 200 day simple moving average of $3.06. SOBR Safe has a 52 week low of $1.27 and a 52 week high of $14.20.
SOBR Safe (NASDAQ:SOBR – Get Free Report) last announced its quarterly earnings results on Wednesday, November 12th. The company reported ($1.44) earnings per share for the quarter. SOBR Safe had a negative return on equity of 93.26% and a negative net margin of 2,265.66%.The company had revenue of $0.11 million for the quarter.
SOBR Safe Company Profile
SOBR Safe, Inc (NASDAQ: SOBR) is a technology company specializing in the development and commercialization of cognitive impairment monitoring solutions. The company’s flagship offerings consist of handheld breath alcohol screening devices and integrated cognitive assessment tools designed to detect impairment in real time. SOBR Safe’s product line pairs portable breathalyzers with proprietary software that captures, records and analyzes impairment data to help organizations maintain safety and compliance standards.
Founded in 2020 and headquartered in Vancouver, Canada, SOBR Safe has focused on research and development of non-invasive impairment detection technology.
Further Reading
- Five stocks we like better than SOBR Safe
- Wall Street Stockpicker Names #1 Stock of 2026
- The Crash Has Already Started (Most Just Don’t See It Yet)
- [How To] Claim Your Pre-IPO Stake In SpaceX!
- Drop these 5 stocks now!
- Trump’s new AI budget just passed — one stock could soar
Receive News & Ratings for SOBR Safe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SOBR Safe and related companies with MarketBeat.com's FREE daily email newsletter.
